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Background: Germany is a country with a high use of herbal medicinal products. Population-based data on the
use of herbal medicinal products among children are lacking. The aim of this study is to investigate the prevalence,
patterns and determinants of herbal medicine use among children and adolescents in Germany.
Methods: As data base served the German Health Interview and Examination Survey for Children and Adolescents
(KiGGS), a representative population based survey conducted 2003–2006 by the Robert Koch Institute. 17,450 boys
and girls aged 0–17 years provided information on drug use in the preceding seven days. Herbal medicinal
products were defined according to the European and German drug laws. SPSS Complex Sample method was used
to estimate prevalence rates and factors associated with herbal medicine use.
Results: The prevalence rate of herbal medicinal product use amounts to 5.8% (95% confidence interval 5.3-6.3%).
Use of herbal medicine declines along with increasing age and shows no difference between boys and girls in
younger age groups. Teenage girls are more likely to use herbal medicines than teenage boys. Two thirds of
herbal medicines are used for the treatment of coughs and colds; nearly half of herbal medicines are prescribed
by medical doctors. Determinants of herbal medicinal product use are younger age, residing in South Germany,
having a poor health status, having no immigration background and coming from a higher social class family.
Children’s and parents-related health behavior is not found to be associated with herbal medicine use after
adjusting for social class.
Conclusions: Use of herbal medicinal products among children and adolescents between the ages of 0 and
17 years in Germany is widely spread and shows relatively higher rates compared to international data. This study
provides a reference on the use of herbal medicinal products for policy-makers, health professionals and parents.
Further studies are needed to investigate the effectiveness and safety of specific herbal medicinal products,
potential effects of long term use as well as possible interactions of herbal medicinal products with concomitantly used
conventional medicines.
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The use of herbal medicinal products for the treatment
and prevention of diseases has a long tradition world-
wide. Nowadays, it still plays an important role in the
health care of numerous divergent societies ranging
from developing countries in Asia and Africa to western
developed nations [1]. In countries with highly devel-
oped health care systems, herbal medicine is often* Correspondence: DuY@rki.de
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unless otherwise stated.regarded as a complementary and alternative medicine
(CAM), thus less common in clinical settings, but has
become increasingly popular in recent years [2-4]. Spe-
cific provisions for herbal medicinal products within the
European and German legal framework dealing with
health care reflect its recognized significance. In this
context, herbal medicinal products are defined as medi-
cinal products containing exclusively herbal active
substances [5,6]. These differ from chemically defined sub-
stances in several aspects; most notably, they consist of
complex multi-component mixtures resulting from, for ex-
ample, extraction of plant parts such as roots and leaves.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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medicinal products have not undergone complex scien-
tific analysis via clinical trials regarding safety and effi-
cacy [7,8]. One of the reasons for this is the fact, that
for the majority of herbal active substances, therapeutic
activity cannot be related to scientifically identified,
chemically defined ingredients, which aggravates con-
ventional clinical studies. Taking into consideration these
particularities of herbal medicinal products, European le-
gislation as well as the German Medicines Act specifically
address resulting characteristics [5,6] and accommodate
adapted rules for marketing authorizations of herbal
medicinal products.
Concerning the use of medicinal products in children
and adolescents, it is generally recognized that pre-
clinical and clinical studies in this field are lacking
regardless of the products’ classification as herbal or
chemically defined products [9]. Additionally, many
medicinal products, particularly herbal medicines, are
used off-label in children [10]. Even though herbal medi-
cinal products are frequently used and regarded as ‘natural’
products, they can also cause adverse drug reactions
[11,12] as well as adverse interactions with other medica-
tions [13,14].
Pediatric use of herbal medicinal products has been
investigated in previous studies mainly under the um-
brella of CAM. However, a differentiation according to
the type of CAM (homoeopathy, herbal medicine, man-
ual therapies, etc.) is necessary as various types of CAM
exhibit diverse characteristics and may have a different
effect on the users’ health. Additionally, users’ profiles
could vary according to type of CAM [15].
Most of the studies are conducted among children
with a specific chronic condition [16-19] or among inpa-
tients and outpatients [20-23]. Internationally, only a few
population-representative studies investigate herbal me-
dicinal product use among children in the general popu-
lation [24-26]. The prevalence of herbal medicinal
product use in these studies is rather low, ranging from
less than 0.5% in the last 7 days among children 0–12
years [25], and 3.9% in the last 12 months among chil-
dren 0–17 years in the USA [26], to 2.4% in the past
3 years among children 0–13 years in Italy [24]. Further
differentiated analysis of patterns and determinants of
herbal medicinal product use is impossible, because of
small numbers of users in these studies [24-26].
Traditionally, Germany is a country with a high use of
herbal medicinal products. A German study conducted
in two birth cohorts [15] and other German studies
among pediatric outpatients with small sample sizes
[20,27,28], support this, but there are no representa-
tive epidemiological studies investigating herbal me-
dicinal product use in the general child population.
The present study attempts to fill this knowledge gap.Using the representative data from the latest German
Health Interview and Examination Survey for Children
and Adolescents (KiGGS), we present here the prevalence
rates, patterns and determinants of herbal medicinal prod-
uct use among non-institutionalized children and adoles-
cents in Germany.
Methods
Data source and study population
The German Health Interview and Examination Survey
for Children and Adolescents (KiGGS) was conducted
by the Robert Koch Institute between May 2003 and
May 2006. In this survey, a highly standardized protocol
encompassing a personal medical computer-assisted inter-
view administrated by physicians (including the drug use
interview), self-administered questionnaires, and standard-
ized physical examinations were conducted [29]. The de-
sign, sampling strategy and study protocol have been
described in detail elsewhere [29]. Briefly, survey partici-
pants were enrolled by a two-stage sampling procedure. In
the first stage, a sample of 167 municipalities was drawn
which were representative of municipality sizes and struc-
tures in Germany. Stratified by sex and age, random sam-
ples of children and adolescents between the ages of 0 and
17 years were then drawn from local population registries
in proportion to the age and sex structure of Germany’s
child population. A response rate of 66.6% resulted in a
final sample of 17,641 children and adolescents. 191 study
participants did not take part in the drug use interview and
were excluded, resulting in a basic population of 17,450
(8,880 boys, 8,570 girls) available for final analysis.
Non-response analysis showed little variation between
the age groups and sexes, and no difference was found
with respect to health-related variables [29,30].
The survey was approved by federal data protection
officials and by the Charité Universitätsmedizin Berlin
medical ethics committee (authorization number: 101/
2000). Written informed consent was obtained prior to
the interview and examination from the children’s parents
and the children themselves if they were aged 14 years or
older. Authors have full access to KiGGS data for this
study.
Data collection
As described elsewhere in detail [29], standardized, age-
specified (0–2, 3–6, 7–10, 11–13 and 14–17 years) self-
filled questionnaires were completed by parents (over
80% of questionnaires were completed by children’s
mothers). Parallel self-filled questionnaires were filled
out by adolescents (11–13 and 14–17 years), including
for example questions on sports activities. Data collected
comprised socio-demographic characteristics, family eco-
nomic background as well as children’s and parents-
related health behavior.
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standardized personal interview conducted by a phys-
ician by the following question:
Has your child taken any medicines in the last seven
days? Please also mention the use of any ointments,
liniments, contraceptive pills, vitamin and mineral
supplements, medicinal teas, herbal medicinal
products and homoeopathic medicinal products.
To facilitate the investigation and verification of drug
use, parents were asked in advance to bring prescrip-
tions or original packages to the examination sites.
In the computer-assisted standardized personal inter-
view, children aged 14 years and older were encouraged
to supplement data on the use of medicines themselves.
Details of medication use were documented, such as
brand name, condition(s) treated (as many as two condi-
tions could be provided and recorded), origin (prescribed
either by a medical docotr, or a non-medical practition,
bought over the counter, or obtained from other sources),
duration of use (<1 week, 1–4 weeks, 1–12 months or
1 year or longer), self-rated improvement of condition(s)
treated (greatly, partly, not much, or not at all), as well as
any adverse drug events following the intake of the medi-
cine. Specific ATC (Anatomical Therapeutic Chemical)
codes were assigned to all reported medications, and
WHO ICD-10 codes to the conditions for which the medi-
cations were taken [31].
Identifying herbal medicinal products from drug database
Of 17,450 study participants, 8,899 were users of medi-
cine. They utilized a total of 14,588 preparations within
the last 7 days. Each preparation was primarily classified
by health care professionals according to the comprising
active substance(s) and categorized as ‘conventional medi-
cinal product’, ‘herbal medicinal product’, ‘homoeopathic
medicinal product’, ‘combination product’, or ‘not attribut-
able’. This process of classification was systematically con-
ducted by consulting at first the German drug dictionary
“Gelbe Liste 2005” [32]. If this information was insuffi-
cient, the “Drug Information System (AMIS)” of the
German Institute of Medical Documentation and Informa-
tion (DIMDI) [33] and then “Rote Liste 2005” [34], another
German drug dictionary, were consulted. If the informa-
tion was still insufficient an internet research was con-
ducted and if this was also unsuccessful the product was
classified as ‘not attributable’.
For the present study, apart from the group of
‘conventional medicinal product’ with clearly chem-
ically defined active substances, all other preparations
were further combed one by one by health care profes-
sionals to control for correct classification into the
specific subgroups. In a second round, experts from BfArM(Federal Institute for Drugs and Medical Devices, Germany)
independently reassessed all these drug classifications.
Bearing in mind their regulatory background, those ex-
perts assigned all herbal medicinal products according
to the definition of Directive 2001/83/EC [5], respect-
ively, the German Medicines Act [6]. Therefore, the
final data for analysis exclusively included those prod-
ucts which could be identified, regardless of the dosage
form, to comply with the legal definitions for ‘herbal medi-
cinal products’ or ‘traditional herbal medicinal products’
as given in current European and German drug law. Other
products such as combination products (containing both
chemically defined and herbal active substances), cos-
metics, food products or medical devices or which could
not be assigned – were excluded from the analysis. The
classification processes came to the result that 10,433
preparations belonged to the group ‘conventional medi-
cinal product’ and 1,152 were identified as herbal medi-
cinal products.
Definition of co-variables
We included several co-variables in the analysis that are
likely to be associated with children’s herbal medicinal
product use. These co-variables cover children’s demo-
graphics (e.g. age, sex, residential region, immigration
background [35]), children’s health status and health be-
havior as well as parental socio-economic status and
health behavior.
-Children’s health status and health behavior
Children’s general health status was rated by their par-
ents with the question ‘How do you rate the health sta-
tus of your child at large?’ The answer choices were
‘excellent/very good’, ‘good’, ‘fair’, ‘bad’ and ‘very bad’.
Further, we used the Children with Special Health Care
Needs (CSHCN) screener tool to identify children with
special health care needs [36].
Children’s body mass index (BMI) was computed
based on measurement of children’s weight and height.
Relative body weight was classified as normal, over-
or underweight according to the criteria of Kromeyer-
Hauschild [37].
Consumption of vegetables and fruit was measured
among children aged 12 months and older with three
questions ‘how often do you/does your child eat: 1) fresh
fruit, 2) cooked or 3) uncooked vegetables?’ Possible
answer choices for each question were based on a
10-point scale ranging from ‘1‘ (never) to ‘10’ (more
than 5 times a day) [38]. The total score which could
be reached by the three questions ranged thus from
a minimum of 3 to a maximum of 30 points. According
to their total score participants were then classified into
‘low’, ‘intermediate’ or ‘high’ vegetables/fruit consumption
groups.
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children 3–17 years only, which was provided by parents
of 3–10 year-old children in the parental self-filled ques-
tionnaires and by 11–17 year-old adolescents in the
child self-filled questionnaires [39].
-Parental social status
Parental social status was defined as lower, intermediate
or upper according to the total score of a composite so-
cial status index integrating the parents’ level of education
(primary, middle, higher and other), household income
(<1500 €, 1500 - <2250 €, 2250 - <3000 €, and > =3000 €)
and profession [40].
-Parents-related health behavior
Children’s exposure to passive smoking at home was de-
fined by the question ‘Is there any smoking at home in
the presence of your child?’, the frequency of which was
categorized as ‘daily’, ‘sometimes’ and ‘never’.
Data on children’s breastfeeding were collected based
on two questions. First, we asked ‘Had your child ever
been breastfed?’ If the answer was ‘yes’, then we asked
‘How long had your child been breastfed exclusively,
that means no extra bottle feeding or complementary
feeding? Answer choices for this question were ‘never
breastfed exclusively’, ‘breastfed exclusively up to XX
months’ (number of months should be given) or ‘do not
know’ [41].
Statistical analysis
IBM SPSS Statistics (version 20, SPSS Inc. Chicago, IL)
was used for statistical analyses. A weighting factor was
used to adjust for deviations of demographic characteris-
tics between the survey population and official popula-
tion statistics (as of 31th December 2004) [30]. This was
a necessary step in order to avoid selection bias caused
by the two-stage sampling procedure. Descriptive statis-
tics were used to examine characteristics of the study
population and prevalence of herbal medicinal product
use. The second-order Rao-Scott chi-square test was
used to test for group differences within specific sub-
groups. We fitted two basic logistic regression models
with ‘herbal medicinal product use’ as the dependent
variable: Model 1 looking at herbal medicinal product
users vs. all children who did not use herbal medicinal
products, model 2 looking at herbal medicinal product
users vs. users of other medicines except for herbal me-
dicinal products. Independent variables in model 1 and
model 2 were: sex, age groups, region 1 (East vs. West
Germany), region 2 (North vs. Central vs. South Germany),
urbanicity (rural areas vs. small vs. medium sized vs. large
cities), BMI, Children with Special Health Care Needs
(according to CSHCN-screener), general health status,
parental social status and immigration background. Oddsratios (OR) and 95% confidence intervals (95% CI) as a
measure of determinants of herbal medicinal product use
were obtained from the basic logistic regression models.
Children’s and parents-related health behavior variables
(sports activities, consumption of fruit and vegetables,
exposure to passive smoking, exclusive breastfeeding)
were then added into the basic models - one by one
separately - to test for independent effects. Because
parents’ educational levels and household incomes
were components of social status, their independent
effects were tested in the basic models with exclusion
of the variable of social status. The large sample size
of this study allows the exclusion of missing values in
multivariable regression modeling without influencing
the results. The SPSS Complex Samples method was
used in the statistical analysis to account for cluster-
ing due to the two-stage sampling procedure. P-values
less than 0.05 and/or 95% CIs that did not overlap were
considered as statistically significant.
Results
Prevalence of herbal medicinal product use
Among 17,450 study subjects, a total of 1,055 children
use at least one herbal medicinal product (Table 1). The
overall weighted user prevalence is 5.8% (95% CI 5.3-
6.3%) with no significant difference (p = .065) between
boys (5.5%, 95% CI 4.9-6.1%) and girls (6.2%, 95% CI
5.5-6.9%). Children younger than 6 years old show a
higher use of herbal medicinal products compared to
children in other age groups. With increasing age, use of
herbal medicinal products declines both in boys and
girls. Significant differences are found between younger
(≤6 years) and older (7–17 years) children. A significant
difference between boys and girls is found in the age
group 14–17 years only, with girls showing a higher use
than boys (3.8% vs. 1.9%, p < .001) (Figure 1). No differ-
ence is found among children residing either in East vs.
West Germany (p = .287), or in North vs. Central vs. South
Germany (p = .181) or in rural areas vs. cities (p = .211)
(data not shown).
Stratified by children’s health status and health be-
havior as well as parental socio-economic status and
parents-related health behavior, a significantly higher
herbal medicinal product use is seen among children
with a poor (fair/bad/very bad) general health status. This
also applies to children engaging moderately (1–2 times/
month and 1–2 times/week) in sports activities, children
with a high vegetable and fruit consumption, children
who had been exclusively breastfed ≥6 months and chil-
dren who had never been exposed to passive smoking at
home. Under the same stratification we also find a signifi-
cantly higher herbal medicinal product use among children
with no immigration background, children whose father
and mother have a higher level of education, household
Table 1 Characteristics of study subjects and prevalence of herbal medicinal product use – by health related indicators
Study subjects Herbal medicinal product users
P***N* %** n* %** 95 %CI
Total 17,450 100 1,055 5.8 5.3-6.3
Children's health status
Parents-rated health status
Excellent 6,873 39.1 366 5.2 4.6-5.9
.002Good 9,250 54.1 592 6.1 5.5-6.8
Fair/bad/very bad 1,102 6.7 92 7.9 6.2-10.0
CSHCN-Screener****
Yes 2,205 13.7 135 6.2 5.1-7.6
.629
No 13,752 86.3 857 5.9 5.4-6.5
Body mass index (BMI)
Underweight 1,121 7.0 80 6.3 4.8-8.2
.136Normal 13,567 78.4 833 5.9 5.4-6.5
Overweight 2,517 14.6 130 4.8 3.8-6.0
Children's health behavior
Sports activities
(children aged 3–17 years only)
Daily 2,335 16.7 89 3.7 3.0-4.7
.000
3-5 times/week 3,119 23.3 142 4.6 3.9-5.6
1-2 times/week 5,811 40.2 353 6.0 5.2-6.8
1-2 times/month 1,306 8.5 100 7.3 5.9-9.2
Never 1,691 11.3 82 4.6 3.6-5.9
Vegetable & fruit consumption
(children aged 1–17 years only)
Low 3,866 26.6 185 4.8 4.0-5.7
.002Middle 7,415 47.2 455 5.9 5.2-6.7
High 4,176 26.2 288 7.0 6.1-8.0
Parental socio-economic status
Immigration background
No 14,790 82.8 957 6.3 5.7-6.9
.000
Yes 2,580 17.2 93 3.5 2.8-4.2
Maternal education level
Primary 3,849 25.4 171 4.3 3.6-5.2
.000
Middle 7,836 40.3 510 6.4 5.6-7.2
Higher 4,838 28.5 339 6.7 6.0-7.6
Others 927 5.7 35 3.5 2.3-5.3
Paternal educationlevel
Primary 4,832 31.7 233 4.7 4.0-5.5
.000
Middle 5,933 28.1 401 6.5 5.6-7.5
Higher 5,100 31.3 368 7.0 6.2-7.9
Others 1,585 9.0 53 3.4 2.5-4.7
Household income per month
<1500 € 3,558 19.0 183 5.0 4.2-6.0
.021
1500 - <2250 € 4,469 26.6 262 5.3 4.5-6.2
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(Continued)
2250 - <3000 € 4,354 27.2 284 6.2 5.4-7.1
> = 3000 € 3,986 27.2 267 6.6 5.8-7.5
Social status
Lower 4,760 27.5 234 4.7 4.0-5.5
.001Intermediate 7,901 45.4 506 6.1 5.4-6.9
Upper 4,366 27.0 307 6.9 6.0-7.8
Parents-related health behavior
Exclusive breastfeeding of children
Never 3,646 22.6 193 5.1 4.3-6.1
.010
Combined with formula milk/unclear 2,493 7.8 130 5.1 4.1-6.3
< 4 months 3,739 20.8 229 5.6 4.8-6.6
4-5 months 3,174 18.5 216 6.5 5.6-7.5
≥ 6 months 3,796 23.5 270 7.0 6.1-8.0
Children exposed to passive smoking at home
Daily 2,612 16.6 102 3.8 3.1-4.8
.000Sometimes 2,236 13.1 121 5.1 4.1-6.2
Never 12,137 70.4 820 6.5 5.9-7.2
*Absolute numbers, unweighted, the sum of subgroups may not be equal to the total because of missing values.
**Percentages, weighted.
***P-values: derived from Rao-Scott chi-square tests for the difference of prevalence estimates within specific groups.
****Children with Special Health Care Needs.
Data source: German Health Interview and Examination Survey for Children and Adolescents (KiGGS) 2003–2006.
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gard to children’s BMI and between children with and
without special health care needs (Table 1).
Patterns of herbal medicinal product use
Of 17,450 study participants 8,899 are users of medicine.
They utilized a total of 14,588 preparations within the
last 7 days. 1,152 (7.9%) of those preparations are herbalFigure 1 Prevalence of herbal medicinal product use by age group an
Examination Survey for Children and Adolescents (KiGGS) 2003–2006.medicinal products. More than two thirds (71.9%) of all
herbal medicinal products are used for the treatment of
cough, common cold and acute upper respiratory infec-
tion (in the following referred to as “coughs and colds”).
The other indications of herbal medicinal products are
less frequently mentioned, all less than 5%. Notably,
3.6% of all herbal medicinal products are used as a
prophylactic measure (Figure 2).d sex. Data source: German National Health Interview and
Figure 2 Indications of herbal medicinal products (N = 1,152). Data source: German National Health Interview and Examination Survey for
Children and Adolescents (KiGGS) 2003–2006. ICD-10, WHO: R05: Cough; J00: Acute nasopharyngitis (common cold); Z29.9: Prophylactic measure;
J06.9: Acute upper respiratory infection; K52.9: Noninfective gastroenteritis and colitis; R07.0: Pain in throat and chest; J32.9: Chronic sinusitis; J40:
Bronchitis, not specified as acute or chronic; L20.8: other atopic dermatitis; R10.4: other and unspecified abdominal pain.
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scribed by medical doctors, which is a significantly lower
prescription rate compared to conventional medicinal
products (67.7%). Herbal medicinal products are more
likely to be used for a shorter term (<1 week) in com-
parison with conventional medicinal products (77.0% vs.
49.8%). In terms of improvement of conditions treated,
compared to conventional medicines, more herbal medi-
cinal products are rated as ‘partly’ (42.4% vs. 35.3%) and
less herbal medicinal products are rated as ‘greatly’ ef-
fective (46.8% vs. 55.9%) (Table 2). When combining the
categories ‘greatly’ and ’partly’ together, herbal medicinal
products are less likely to improve the conditions treated
than conventional medicinal products (89.2%, vs. 91.2%,
p = .042, data not shown in Table 2). However, 3.3% of
herbal medicinal products show no effect at all, which
does not significantly differ from conventional medicinal
products (2.6%). Overall, 10 adverse drug events are re-
corded among herbal medicinal products with a propor-
tion of 0.9% compared with 125 adverse drug events
(1.2%) recorded among conventional medicinal products
(p >0.05, data not shown).
Of 1,152 herbal medicinal products, 711 (61.7%)
are mono-products containing one herbal active sub-
stance. 231 (20.1%) are combination products with
two herbal active substances while 210 (18.2%) are
combination products with multiple herbal active sub-
stances (range 3–9). Ivy leaves are used most fre-
quently, found in one third (32.2%) of all herbal
medicinal products and in 43.9% of mono-herbal medi-
cinal products (Table 3). Among combination products
with two herbal active substances, eucalyptus leaves with
pine needles (31.2%) is the most frequently reportedcombination, followed by the combinations of thyme
herbs with ivy leaves (24.7%), thyme herbs with primrose
roots (22.5%) and eucalyptus leaves with spruce-needles
(9.5%) (data not shown).
Determinants of herbal medicinal product use
A multivariable regression model with herbal medicinal
product users vs. all children who did not use herbal
medicinal products (model 1) shows the following re-
sults: Herbal medicinal product use among the pediatric
population is significantly and positively associated with
younger age, residing in the south of Germany, having
no immigration background, having a poor general health
status and coming from families with higher socio-
economic status (Table 4, model 1). Comparable determi-
nants with exception of a positive CSHCN-screener are
also found in model 2 with herbal medicinal product
users vs. users of other medicines (except herbal medi-
cinal products) as the dependent variable. Children with
special health care needs are less likely to use herbal
medicinal products (Table 4, model 2). No association is
found for sex, region 1 (East vs. West), urbanicity (rural
areas vs. small vs. medium sized vs. large cities) and BMI
in both model 1 and model 2 (all p > .05, data not shown).
Adding children’s and parents-related health behavior
variables including sports activities, consumption of fruit
and vegetables, exposure to passive smoking at home
and exclusive breastfeeding - one by one independently -
into the two basic models, no associations with usage of
herbal medicinal products are found to be statistically
significant (data not shown).
Replacing social status with maternal and paternal
education levels or household income - one by one
Table 3 The 10 most frequently used herbal active
substances (unprocessed herbal substances or herbal
preparations) in mono- and in all herbal medicinal
products
Herbal medicinal
mono-products (n = 711)
n (%) All herbal medicinal
products (N = 1152*)
n (%)
Ivy leaf 312(43.9) Ivy leaf 371(32.2)
Pelargonium root 112(15.8) Thyme herb 217(18.8)
Thyme herb 71(10.0) Eucalyptus leaf 133(11.5)
Saccharomyces boulardii 37(5.2) Pelargonium root 111(9.6)
Purple coneflower herb 22(3.1) Elder flower 77(6.7)
Ribwort plantain herb 15(2.1) Primula flower 77(6.7)
Evening primrose seed 11(1.5) Verbena herb 77(6.7)
Iceland moss 10(1.4) Gentian root 77(6.7)
Fennel fruit 9(1.3) Sorrel herb 77(6.7)
Matricaria flower 7(1.0) Matricaria flower 75(6.5)
Data source: German Health Interview and Examination Survey for Children
and Adolescents (KiGGS) 2003–2006.
Table 2 Patterns of herbal compared to conventional medicinal product use
Herbal medicinal products Conventional medicinal products P*
n % 95% CIs n % 95% CIs
Total number of drugs 1,152 100 - 10,433 100 -
Origin
Prescribed by doctors 510 44.5 41.65-47.39 7012 67.7 66.8-68.6 .000
Bought OTC 425 37.1 34.34-39.92 2077 20.1 19.3-20.8
Obtained from other sources 211 18.4 16.28-20.77 1264 12.2 11.6-12.9
Missing 6 80
Duration of use
<1 week 882 77.0 74.4-79.3 5114 49.8 48.8-50.8 .000
1-4 weeks 221 19.3 17.1-21.7 1409 13.7 13.1-14.4
1-12 months 25 2.2 1.5-3.2 2022 19.7 18.9-20.5
1 year or longer 18 1.6 1.0-2.5 1724 16.8 16.1-17.5
Missing 6 164
Self-rated improvement of conditions treated
Greatly 505 46.8 43.9-49.8 3841 55.9 54.7-57.0 .000
Partly 457 42.4 39.5-45.4 2426 35.3 34.1-36.4
Not much 80 7.4 6.0-9.2 427 6.2 5.7-6.8
Not at all 36 3.3 2.4-4.6 181 2.6 2.3-3.0
Doesn’t apply** 39 3199
Missing 35 359
Tolerance of drug use
Very good/good 1,130 98.9 98.1-99.4 10182 98.4 98.2-98.6 .163
Partly/not tolerated 12 1.1 0.6-1.9 164 1.6 1.4-1.8
Missing 10 87
*P-value: chi-square test for differences in proportions between herbal and conventional medicinal products.
**Drugs were used e. g. as a preventive measure, for contraception, or diagnosis was unknown.
Data source: German Health Interview and Examination Survey for Children and Adolescents (KiGGS) 2003–2006.
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nal and paternal education levels, but not household in-
come, are statistically significant (data not shown).
Discussion
Principle findings
In a national representative sample of children and ado-
lescents aged 0–17 years in Germany, 5.8 % of study par-
ticipants utilized herbal medicinal products within the
last 7 days. Use of herbal medicinal products declines
along with increasing age and shows no difference be-
tween boys and girls in younger age groups. Teenage
(14–17 years) girls are more likely to use herbal medi-
cinal products than teenage boys. Two thirds of herbal
medicinal products are used for the treatment of coughs
and colds; nearly half of herbal medicinal products are
prescribed by medical doctors. Use of herbal medicinal
products is closely associated with younger age, residing
in the south of Germany, having a poor health status,
Table 4 Determinants of herbal medicinal product use










Age group in years
0 – 2 4.21 3.19-5.56 2.72 2.04-3.62
3 – 6 3.71 2.82-4.88 3.80 2.88-5.02
7 – 10 1.84 1.37-2.47 2.27 1.68-3.07
11 – 13 1.61 1.20-2.15 2.02 1.50-2.73
14 – 17 1
Region 2
Northern 1 1
Central 1.23 0.97-1.55 1.27 1.02-1.58
Southern 1.37 1.05-1.79 1.32 1.02-1.70
Immigration
background




Good 1.48 1.28-1.70 1.31 1.13-1.53
Fair/bad/very bad 2.17 1.59-2.98 1.67 1.20-2.32
CSHCN-screener***




Intermediate 1.32 1.10-1.60 1.28 1.05-1.56
Higher 1.41 1.14-1.73 1.29 1.04-1.60
OR = odds ratio, 95% CI = 95% confidence interval.
*Herbal medicinal product users vs. those who do not use herbal medicinal
product as the dependent variable.
**Herbal medicinal product users vs. users of other medicine (except for
herbal medicinal products) as the dependent variable.
***Children with Special Health Care Needs.
Other variables included in model 1 and model 2: sex, region 1 (East vs. West),
urbanicity (rural areas vs. cities) and BMI.
Data source: German Health Interview and Examination Survey for Children
and Adolescents (KiGGS) 2003–2006.
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higher social class family. Children’s and parents-related
health behavior is not found to be associated with herbal
medicinal product use after adjusting for social class.
Prevalence of herbal medicinal product use
Many factors can influence the prevalence rates, which
vary considerably between studies depending on study
methodology. Any comparisons between studies should
consider differences in study population, observationalwindow, data collection mode, definition of herbal medi-
cinal products etc. Most international studies are con-
ducted among children with a specific chronic condition
[16,18] or among inpatients and outpatients [20-22] and
show a higher herbal medicinal product use. Longer ob-
servational windows cover more herbal medicinal prod-
uct use and thus account for higher prevalence rates.
The prevalence estimate of herbal medicinal product
use found in our study is higher than rates reported in a
study with a similar setting from the USA. The Slone
Survey, a telephone survey of medicine use in the US
population, collected data on the use of prescription and
non-prescription medication including herbal products/
natural supplements during the previous week [25]. Re-
sults of this survey report a rather low use of herbal
medicine in the past 7 days at < 0.5% among children 0–
12 years [25]. In comparison, our 7-days prevalence
amounts to 5.8% among children aged 0–17. The rather
low herbal medicine use among US children is con-
firmed by the results of the 2007 National Health Inter-
view Survey, in which the 12-month prevalence rate of
natural products usage (mostly herbal medicines) among
children aged 0–17 years amounts to 3.9% [26]. Even
among US-children presented for surgery, only 3.5% of
the patients had been given herbal or homoeopathic
medications in the preceding 2 weeks [42].
In a population-representative sample of approxi-
mately 6,000 Italian families, unconventional medicinal
product use is investigated in the frame of a study on
‘Health conditions and health service utilization’ [24,43].
Prevalence of herbal medicine use among children aged
0–13 years during the 3-years period between 1997 and
1999 amounts to 2.4% [24]. Similarly, an investigation in
South Australia including 911 children aged 15 years or
less finds that 168 children (18.4%) use CAM in the pre-
vious 12 months. One third of these CAM users (n = 56)
are herbal medicine users [44], which equals a 12-month
prevalence rate of 6.1%. An investigation into the use of
Traditional Chinese Medicine (TCM), an Asian medi-
cine system consisting mainly of herbal medicine ther-
apy, among 5,971 Chinese children in Taiwan finds that
4.7% of the participants used TCM within the past
month [45]. Even though the prevalence rates of the
South-Australian [44] and Taiwanese [45] studies come
close to our results, it is difficult to compare rates as the
observation periods vary greatly.
Herbal medicine and homoeopathy are the two fre-
quently used CAMs in German-speaking countries
[15,27,28,46]. Based on KiGGS data, we previously re-
ported a pediatric homoeopathic medicinal product use
of 4.6% [47] in Germany, slightly lower than herbal me-
dicinal product use in the present study (5.8%). Another
German study including two birth cohorts of a total of
3,642 children shows a 4-weeks prevalence rate of herbal
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use of 8.9% and 14.3%, respectively [15], both higher
than KiGGS results. Yet, methodologically, this study is
not comparable to KiGGS, as they look at a different age
group (9.4 to11.6 vs. 0 to 17 years) and the observation
period differs from KiGGS (4 weeks vs. 7 days) [15].
Additionally, the proportion of children’s parents with
higher education and income levels is overrepresented
compared to German national means [15], which may
contribute to a higher use of herbal and homoeopathic
medicinal products.
Possible reasons for a high herbal medicinal product
use in our study compared to international analyses are
various. In Germany, the treatment of children under
12 years and of children with developmental disorders
up to 18 years, with herbal or other alternative medicine
is reimbursed by the health insurance, even if the medi-
cation is available without a prescription (over the coun-
ter, OTC). Further, OTC herbal medicinal products can
be recommended or prescribed by non-medical practi-
tioners called ‘Heilpraktiker’ in Germany. A Heilpratiker
receives no university medical school training but ob-
tains a state license after passing a specific examination
usually after completion of an optional medical know-
ledge course [48]. The number of non-medical practi-
tioners Heilpraktiker has increased recently in Germany
[49,50], possibly playing a role in the increase of herbal
medicinal product use. Nevertheless, in the comparison
between studies, we should also bear in mind the differ-
ences in the definition of herbal medicinal product,
which may lead to different prevalence rates. Differences
in cultural and traditional background as well as differ-
ences in access to health care systems can influence the
prevalence rates of studies in different countries.
Patterns of herbal medicinal product use
Similar to our study, previous studies conducted in
Germany investigating the patterns of herbal medicinal
product use also find that the vast majority of herbal
medicinal products are used to treat coughs and colds,
followed by herbal treatments for intestinal disorders
[15,20]. The predominance of the indications which can
be summarized as coughs and colds is in line with the
fact, that most of newly licensed herbal medicinal prod-
ucts belong to this therapeutic area [51]. In the present
study almost half of all herbal medicinal products are
prescribed by medical doctors, which is significantly less
compared to that of conventional medicinal products,
but significantly more compared to homoeopathic medi-
cinal products (about 25%) [47]. Concerning the effect-
iveness of treatment, we find that nearly half (46.8%) of
all herbal medicinal products can improve the condition
treated ‘greatly’, which is significantly lower than that of
conventional medicinal products (55.9%). A differentpattern occurs when looking at the answer category
’condition improved partly’; significantly more herbal
medicinal products than conventional medicinal prod-
ucts were rated to be ‘partly’ effective. Overall, only a
very small part (3.3%) of herbal medicinal products is
rated to be not effective at all, which shows no differ-
ence from that of conventional medicinal products.
However, this does not allow any conclusion on effect-
iveness when comparing herbal and conventional medi-
cinal products, as there are differences in the conditions
treated by the two types of medicines. Two thirds of
herbal medicinal products are used for the treatment of
coughs and colds, which in most cases are self-limiting
diseases in children. In contrast, conventional medicinal
products are used for the treatment of a wide range of
acute and chronic conditions.
Determinants of herbal medicinal product use
Determinants of herbal medicinal product use in the
present study include children residing in South Germany,
and coming from families with higher socio-economic
status, mainly educational level. This is well in line with
results of a previous regional population-based study
conducted in Germany [15]. This study finds that herbal
medicinal product use is significantly positively associ-
ated with a higher maternal educational level, but reversely
associated with living in West (Wesel-area) compared with
South Germany (Munich) [15]. Children of families with
higher socio-economic status are found to have a signifi-
cantly higher use of CAM [52] including herbal medicines
[45]. Like in our study, household income is not found to
be associated with herbal medicinal product use [15]. The
influence of social status can be explained by maternal and
paternal education levels, but not by household income in
our study. Possibly, this may be due to the fact that herbal
medicinal products prescribed for children less than
12 years are reimbursed by health insurances in Germany.
Children with immigration background in Germany are as-
sociated with a lower parental socio-economic status [35],
this might be one of the reasons why they are less likely to
use herbal medicinal products. Other possible reasons
could be rooted in cultural and religious differences among
children with immigration background. Previous studies
have shown that in German-speaking countries homoeo-
pathic medicine use is more common in families with no
immigration background [47]. Yet, an American study [53]
found no difference in herbal medicine use according to
race and country of origin of the child. Another American
study looking at low-income, nutritionally vulnerable chil-
dren found that the use of herbals is more common among
Latino children compared to all other children of the study,
but does not differ among the two states in which the stud-
ies were conducted (Wisconsin and Kansas) [22]. Younger
children < 6 years are the main herbal medicinal product
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ceptance of herbal medicinal products based on the as-
sumption that herbal medicine is ‘mild’ and associated with
less undesirable effects than allopathic medicine [54]. This
popular attitude may be decisive especially for the treat-
ment of young children who are considered to be the most
vulnerable group.
In our study the CSHCN-screener is found not to be
associated with herbal medicinal product use in the lo-
gistic regression model 1 while inversely associated with
herbal medicinal product use in model 2. This implies
that children with special health care needs are more
likely to be treated with conventional medicinal products
rather than herbal medicinal products.
Strengths and limitations
One of the strengths of our study can be seen in the in-
clusion of a large population-representative community
sample of a national health survey. Further, we asked
survey participants/children’s parents to bring the ori-
ginal packages and/or inserts to the examination sites
for the purpose of verification of drug use, and we inves-
tigated medicine use for a short period of 7 days prior to
the interview, both contributing to reduce recall bias.
Classification of herbal medicinal products in the present
study was confirmed independently by health care profes-
sionals and regulatory experts of federal pharmaceutical
supervising authorities. In this way, misclassification bias is
reduced to the least degree.
However, there are several limitations to our study.
First, our study subjects are children living in communi-
ties; children with severe medical diseases requiring in-
patient treatment are not included in our study. These
children may have a different pattern of medication use,
including herbal medicinal products. Second, subject to
cross-sectional design, our study does not allow to draw
any causality conclusions. Third, though we cover as
many influence factors as possible in the regression
models, other factors that may have a substantial influ-
ence on children’s health are not considered. So could
for example, the severity of a disease influence the use of
alternative medicine [55].
Conclusions
In summary, we found a relatively high use of herbal
medicinal products among children in Germany in com-
parison with children from other countries. Herbal me-
dicinal products are mainly used for the treatment of
coughs and colds among children. A high proportion of
herbal medicinal products is prescribed by medical doc-
tors, suggesting a certain degree of acceptance among
medical doctors in Germany. Determinants of herbal
medicinal product use include younger age, residing in
South Germany, having a poor health status, having noimmigration background and a higher parental socio-
economic status, mainly educational level. Children's
and parents-related health behaviors are found not to be
associated with herbal medicinal product use after
adjusting for social class. Findings of this study provide
essential data and a reference on the use of herbal medi-
cinal products for policy-makers, health professionals
and parents. Further studies are needed to investigate
the effectiveness and safety of specific herbal medicinal
products, potential effects of long term use as well as
possible interactions of herbal medicines with concomi-
tantly used conventional medicinal products.
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